To optimize and validate at lab scale the most efficient lutein-loaded DDS for the prevention/treatment of cataract/angiopathy in animal model.

1. Comparative assessment of lutein delivery efficiently to the anterior and posterior segments of the eye as co-crystals

2. Elucidation of most likely lutein delivery mechanism based on the nanocarrier’s fabrication variables (charge, size)